Literature DB >> 21478207

Serum concentrations of insulin-like growth factor-I, insulin-like growth factor binding protein-3 and cardiovascular risk factors in adolescents.

Alice P S Kong1, Kai-Chow Choi, Gary W K Wong, Gary T C Ko, Chung-Shun Ho, Michael H M Chan, Risa Ozaki, Ronald C W Ma, Joseph T F Lau, Juliana C N Chan.   

Abstract

BACKGROUND: The risk association between the insulin like growth factor-I (IGF-I) system and cardiovascular risk is inconclusive in adults and under-explored in adolescents. We aimed to investigate the associations between serum concentrations of IGF-I and IGF binding protein-3 (IGFBP-3) and cardiovascular risk factors in adolescents.
METHODS: This was a cross-sectional, population-based, observational study in a school setting with 2102 Hong Kong Chinese adolescents aged 12-19 years. Serum IGF-I and IGFBP-3 concentrations were measured by chemiluminescence immunoassays. Anthropometric indices and traditional cardiovascular risk factors were assessed.
RESULTS: After excluding participants with abnormal thyroid and liver test results, 765 boys and 877 girls, mean (±SD) age of 15.3 (±2.0) and 15.7 (±2.0) years, respectively, were included in the analysis. Multivariable regression analyses revealed that both IGF-I and IGFBP-3 concentrations were independently associated with waist circumference, fasting insulin and haemoglobin concentrations in boys (all P < 0.05), systolic blood pressure, serum creatinine, fasting insulin and haemoglobin concentrations in girls (all P < 0.05). In girls, IGF-I was also associated with C-reactive protein concentration (P < 0.001) and IGFBP-3 was associated with fasting triglyceride concentration (P < 0.001). Compared with adolescents with the lowest tertile, the top tertile of both IGF-I and IGFBP-3 concentrations were associated with increased odds of having overweight/obesity, top tertiles of insulin and haemoglobin in both boys and girls (P for trend, all <0.05).
CONCLUSIONS: The associations between serum IGF-I, IGFBP-3, obesity, cardiovascular risk factors, insulin and haemoglobin suggest that dysregulation of the IGF system may play a linking role for the clustering of cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21478207     DOI: 10.1258/acb.2011.010267

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  5 in total

Review 1.  The maternal womb: a novel target for cancer prevention in the era of the obesity pandemic?

Authors:  Frank A Simmen; Rosalia C M Simmen
Journal:  Eur J Cancer Prev       Date:  2011-11       Impact factor: 2.497

2.  Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents.

Authors:  Lorraine E Levitt Katz; Kevin A Gralewski; Pamela Abrams; Preneet C Brar; Paul R Gallagher; Terri H Lipman; Lee J Brooks; Dorit Koren
Journal:  Pediatr Diabetes       Date:  2014-12-10       Impact factor: 4.866

3.  Protein Intake from Birth to 2 Years and Obesity Outcomes in Later Childhood and Adolescence: A Systematic Review of Prospective Cohort Studies.

Authors:  Alexandra Stokes; Karen J Campbell; Hong-Jie Yu; Ewa A Szymlek-Gay; Gavin Abbott; Qi-Qiang He; Miaobing Zheng
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

Review 4.  The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus.

Authors:  Moira S Lewitt; Mairi S Dent; Kerstin Hall
Journal:  J Clin Med       Date:  2014-12-22       Impact factor: 4.241

5.  Aging and sex affect soluble alpha klotho levels in bonobos and chimpanzees.

Authors:  V Behringer; J M G Stevens; T Deschner; R Sonnweber; G Hohmann
Journal:  Front Zool       Date:  2018-09-19       Impact factor: 3.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.